Companies/JP/7774

Japan Tissue Engineering Co.,Ltd. · 株式会社ジャパン.ティッシュエンジニアリング

Income flow

Annual
7774 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
Regenerative Medicine BusinessJPY 1BCustom Development And Manufacturing BusinessJPY 546MLab Cyte BusinessJPY 282MRevenueJPY 2B-11% Y/YGross profitJPY 1B-16% Y/YCost of revenueJPY 915M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-31 · ANNUAL · JPY
By activity
By activityJPY 2.2B
  • Regenerative Medicine BusinessJPY 1.4B62.0%
  • Custom Development And Manufacturing BusinessJPY 546M25.0%
  • Lab Cyte BusinessJPY 282M12.9%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).40.6MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).11.0M
Stock splits
  1. 200:12014-03-27